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Abstract We found polysialie acid synthase activity of ST8Sia 
II (STX) in vitro and in vivo. Previously, we showed that mouse 
ST8Sia II exhibits ~2,3-sialylated N-glycan a2,8-sialyltrans- 
ferase activity, but the polysialic acid synthase activity of ST8Sia 
II was not detected at that time [Kojima, N. et al. (1995) FEBS 
Lett. 360, 1-4]. When fetuin was [14C]sialylated with ST8Sia I1 
and then its N-linked oligosaccharides were analyzed, a part of 
the N-linked oligosaccharides was eluted in the void volume from 
a Sephadex G-50 column, and was eluted from the DEAE- 
Toyopearl column at almost the same salt concentration as that 
where colomic acid was elnted. In addition, a series of 14C-labeled 
oligo-sialic acids were obtained from the oligosaccharides on par- 
tial mild acid hydrolysis. These results indicated that a part of 
N-linked oligosaccharides of fetuin were polysialylated with 
ST8Sia II. Transfection of ST8Sia II gene into several cell lines 
including NIH3T3 led to the expression of polysialic acids on the 
cell surface. Thus, ST8Sia lI can directly synthesize polysialic 
acid chains on ot2,3-sialylated N-linked oligosaccharides of 
glycoproteins without any initiator sialyltransferase. 
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1. Introduction 
Oligo- and poly-sialic acids are ubiquitous in the oligosac- 
charides of glycoconjugates in a wide variety of animals [1]. It 
has been reported that Siact2,8Sia-sequences are associated 
with only two mammalian proteins, the neural cell adhesion 
molecule (N-CAM) [24] and the ~-subunit of the voltage-gated 
sodium channel in rat brain [5]. Recently, we cloned three 
similar but different ypes of sialyltransferase g ne (ST8Sia II, 
III and IV) from mouse cDNAs. By transfecting these clones 
into COS cells, we identified their activities as those of the 
N-glycan ~2,8-sialyltransferases [7-9]. Among them, mouse 
ST8Sia II, which is a homologue of a rat developmentally 
regulated sialyltransferase (STX) reported by Livingston and 
Paulson [6], exhibited N-glycan ~2,8-sialyltransferase activity 
[7], but the polysialic acid (PSA) synthase activity was not 
detected at that time. More recently, we detected ct2,3-sialylated 
N-glycan ~2,8-PSA synthase activity of mouse ST8Sia IV, 
which is a homologue of hamster polysialyltransferase I re- 
ported previously [9,10]. Strikingly, the predicted amino acid 
sequence of ST8Sia II exhibits high identity to that of ST8Sia 
IV (56.0%), suggesting that the enzymatic activity of ST8Sia II 
may be similar to that of ST8Sia IV. Here we report the PSA 
synthase activity of mouse ST8Sia II (STX) in vitro and in vivo. 
2. Materials and methods 
2.1. Materials 
Unless otherwise indicated, the materials used in this study were 
essentially the same as in the previous tudies [7,8]. Fetuin was from 
Sigma. Protein A-Sepharose and Sephadex G-50 superfine were from 
Pharmacia, and DEAE-Toyopearl 650M from Toso. Di-, tri-, tetra-, 
and hexa-sialic acids, which are products of partial hydrolysis of colo- 
mic acid, were gifts from Nihon Gaishi Co. The polyclonal anti-poly- 
sialic acid antibody, H.46, which was established by Allen et al. [11], 
and the monoclonal nti-polysialic acid antibody, mAb 735, which was 
established by Frosch et al. [12], were kindly provided by Prof. Inoue, 
Tokyo Univ., Tokyo, Japan, and Dr. R. Gerady-Schahn, I st. ffir Med. 
Mikrobiologie, Hanover, Germany, respectively. Lipofectamine and 
NANase II (specific for ct2,3- and ~2,6-1inked sialic acids) were from 
Gibco BRL and Glyko Inc., respectively. 
2.2. Sialyltransferase assays and preparation of oligosaccharides 
The vector plasmid designated as pcDSA-O1, consisting of cDNAs 
encoding an IgM signal peptide sequence, a protein A IgG binding 
domain and the truncated soluble form of ST8Sia lI, was prepared as 
described previously [7]. COS-7 cells were transiently transfected with 
10/lg each of the plasmid, using the DEAE-dextran procedure, and 
cultured, and then the enzyme was prepared from the culture medium 
as previously described [7]. Fetuin (1 mg) was sialylated in the presence 
of 0.1 M sodium cacodylate buffer (pH 6.0), 10 mM MgC12, 2 mM 
CaC12, 100 ,uM CMP-[~4C]NeuAc (2.5/ICi), and 50/.tl enzyme prepara- 
tion, in a total volume of 200/4 [7]. After incubation at 37°C for 24 
h, the reaction mixture was centrifuged and the supernatant was col- 
lected. To remove excess CMP-[14C]NeuAc, the protein was precipi- 
tated with 70% ethanol and dried. [~4C]Sialylated oligosaccharides were 
prepared from [~4C]sialylated fetuin by hydrazinolysis (gas phase, 
110°C for 1 h, Hydoraclub C-206, Honen) followed by N-acetylation, 
and then subjected to chromatography on a Sephadex G-50 column 
(1 x 120 cm) equilibrated with 50 mM ammonium acetate (pH 5.2). 
Fractions of 1 ml were collected and the radioactivity in an aliquot of 
each (100 ,ul) was counted with a scintillation counter. The radioactive 
oligosaccharides were pooled, dried, and then subjected to chromatog- 
raphy on a DEAE-Toyopearl 650M column (1 x 7 cm) with a linear 
gradient of ammonium acetate (5 200 mM or 5 500 mM). Fractions 
of 1 ml were collected. The terminal ct2,3- and c~2,6-1inked sialic acids 
of the oligosaccharides were removed by treatment with ct2,3- and 
~2,6-specific sialidase (NANase II; 0.5 U/ml) for 37°C for 16 h, and 
then the sialidase-treated oligosaccharides were subjected to chroma- 
tography on a Sephadex G-50 column and then a Toyopearl 650M 
column. 
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2.3. Transfection of the sialyltransJerase gene into cells 
The DNA containing the full open reading frame of ST8Sia II was 
ligated into the cloning site of the mammalian expression vector, pRc/ 
CMV. Murine fibroblast NIH3T3 cells, murine neuroblastoma 
Neuro2a cells, and murine melanoma BI6 BL6 cells were maintained 
and grown in DMEM supplemented with 10% FCS on 3 cm diameter 
dishes (Falcon). Plasmid DNA (2 Hg) of pRc/CMV or pRc/CMV- 
ST8Sia II was transfected into the cells by means of lipofectamine 
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according to the manufacturer's in tructions. After culturing for 72 h 
in DMEM supplemented with 10% FCS, the cells were fixed with 1% 
paraformaldehyde and stained with the anti-polysialic a id antibodies, 
H.46 (1:100 dilution) and mAb 735 (5 pg/ml) [11,12] followed by stain- 
ing with anti-horse IgM and the mixture of anti-mouse IgG and anti- 
mouse IgM, respectively, and then analyzed by fluorescent microscopy 
and subjected toflow cytometry using FACSFIow (Becton Dickinson). 
In another case, protein A-fused, soluble STSSia II was transiently 
expressed in NIH3T3 cells by transfection with plasmid pcDSA-O1 
(encoding soluble ST8Sia II), followed by staining with H.46. 
3. Results 
To clarify the PSA synthase activity of ST8Sia II (STX) in 
vitro, fetuin was [~4C]sialylated with protein A-fused soluble 
ST8Sia II (product of plasmid pcDSA-O 1), the N-linked oligo- 
saccharides were prepared by hydrazinolysis and separated on 
a Sephadex G-50 column. Fig. 1A shows the gel filtration pat- 
tern of the sialylated N-linked oligosaccharides. Most of the 
radioactivity was retained on the G-50 column, but a part of 
it was eluted in the void volume of the column (Peak A). The 
amount of the Peak A material was very small for fetuin sialyl- 
ated for 6 h, but dramatically increased on 24 h incubation. On 
the other hand, the Peak B material was mostly synthesized 
within 6 h, the amount reaching a plateau after 10 h incubation 
(data not shown). These results suggested that the Peak A 
material was synthesized from the Peak B one by ST8Sia I1 
itself. Each peak was pooled, dried, and then subjected to ion- 
exchange chromatography on a DEAE-Toyopearl column. The 
major oligosaccharides in Peak B were eluted between the posi- 
tions where tri-sialic acid and tetra-sialic acids were eluted (Fig. 
1B). The Peak B material eluted from the DEAE-Toyopearl 
column was then treated with ~2,3- and c~2,6-1inked specific 
sialidase (NANase II). During such treatment, terminal e2,3- 
and c~2,6-1inked sialic acids on the oligosaccharides are elimi- 
nated, but ~2,8-sialic acid residues incorporated by the enzyme 
are resistant. The molecular weight of material in Peak B after 
removal of ~2,3- and c~2,6-1inked sialic acids was slightly 
smaller than that before the treatment with NANase II, how- 
ever, free sialic acids were not released uring the treatment, 
indicating that the incorporated sialic acids were most probably 
~2,8-1inkages and only part of the blanches of N-oligosac- 
charides was ~2,8-sialylated (Fig. 1C). The NANase lI-treated 
Peak B material was then subjected to ion-exchange chroma- 
tography on the same DEAE-Toyopearl column (Fig. I B). 
Peak B after treatment with NANase II was eluted at the 
positions of di- and tri-sialic acids, suggesting that the oligosac- 
charides possessed one Sia0~2,8Sia residue or Siac~2,8Sia~2,8Sia 
residue. 
ST8Sia II can synthesize the materials that are eluted in 
the void volume from the Sephadex G-50 column, as shown in 
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Fig. 1. Chromatography of N-linked oligosaccharides rived from sialylated fetuin and effect of NANase II. (A) Inset." SDS-PAGE pattern of fetuin 
sialylated with STSSia II for 6, 10, 14 and 24 h, respectively. The sialylated fetuin (1 mg) incubated for 6 h (e) or 24 h (o) in the inset was then subjected 
to hydrazinolysis, followed by acetylation. The resulting N-linked oligosaccharides were subjected tochromatography on a Sephadex G-50 column 
(1 × 120 cm) equilibrated with 50 mM ammonium acetate (pH 5.2). One ml fractions were collected and 100 ~tl aliquots of which were counted. (B and 
C) The Peak B material was subjected tore-chromatography on the same column (B) or on a DEAE-Toyopearl column, with a linear gradient of 
5-200 mM ammonium acetate, before (o) and after (e) treatment with NANase II for 16 h at 37°C. Arrows under (Sia)2, (Sia)3, (Sia)4 and (Sia)6 
indicate the elution positions of di-, tri-, tetra and hexa sialic acids, respectively. 
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Fig. 2. Presence of polysialic acid chains in N-linked oligosaccharides. 
(A) The Peak A material in Fig. IA was subjected to chromatography 
on a DEAE-Toyopearl column with a linear gradient of 5-500 mM 
ammonium acetate, before (©) and after (e) treatment ofNANase II. 
(B) The Peak A material after treatment with NANase II was hydro° 
lyzed with 50 mM ammonium acetate buffer (pH 5.4) at 80°C for 3 h. 
The hydrolysate was diluted with water and then applied to a DEAE- 
Toyopearl column as described above. 
Fig. 1A. When the Peak A material was applied on a DEAE- 
Toyopearl column (Fig. 2A), it was eluted from the column at 
the salt concentration of about 400 mM, where is higher than 
the elution position of hexa-sialic acids and almost he same as 
that where colomic acid was eluted. After treatment with 
NANase II, the elution position of Peak A material from the 
column was at a relatively lower salt concentration than that 
before sialidase treatment, but still higher than that of hexa- 
sialic acid and no free sialic acids were observed. To determine 
whether these materials contain polysialic acids or not, they 
were partially hydrolyzed with mild acid (pH 5.4, 80°C, for 3 h) 
and then applied on a DEAE-column [13]. A series of radio- 
active oligo-sialic acids (DP 1-10) was released from Peak A 
on hydrolysis of the materials (Fig. 2B). These results strongly 
indicated that the materials in Peak A derived from sialylated 
fetuin contain polysialic acid chains, and ST8Sia II exhibits 
polysialyltransferase ctivity toward N-glycosylated glycopro- 
reins, at least in vitro. 
In view of the polysialic acid expression on NIH3T3 cells on 
transfection of the hamster polysialyltransferase-1 gene [10], we 
tried to transfect he mouse gene into several cell lines for 
polysialylation of the proteins in vivo. NIH3T3 cells were tran- 
siently transfected with the plasmid, pcDSA-O1 (encoding sol- 
uble ST8Sia II). Since the pcDSA-O 1 derived enzyme have been 
used for determination of in vitro PSA synthase activity, the 
active enzyme should be expressed in the cells by transfection 
of the plasmid. The transfection ofpcDSA-O1 led to the expres- 
sion of H.46-reactive polysialic acids on cell surface (Fig. 3A). 
When the full-length ST8Sia II gene was transfected into NIH 
3T3, Neuro2a or B 16 BL6 cells, which express N-CAM (identi- 
fied by anti-N-CAM monoclonal antibody, H.28), polysialic 
acids were strongly expressed on all three cell lines (Fig. 3B and 
C). These results indicate that ST8Sia II is able to synthesize 
polysialic acid chains in vivo. 
4. Discussion 
The following results strongly indicated that mouse ST8Sia 
II also exhibits PSA synthase activity in vitro and in vivo, in 
addition to previously reported N-glycan ~2,8-sialyltransferase 
activity [7]: (i) a part of [~4C]N-linked oligosaccharides derived 
from sialylated fetuin with ST8Sia II was eluted in the void 
volume from the Sephadex G-50 column; (ii)the materials 
eluted in the void volume from the column were eluted from 
the DEAE-Toyopearl column at almost he same salt concen- 
tration as that where colomic acid was eluted; (iii) a series of 
~4C-labeled oligo-sialic acids was obtained on partial mild acid 
hydrolysis of the N-linked oligosaccharides; (iv) the transfec- 
tion of cDNAs encoding ST8Sia II into three different cells led 
to strong expression of polysialic acids on the cell surface. Thus, 
ST8Sia II is able to directly synthesize polysialic acid chains on 
~2,3-sialylated N-linked oligosaccharides of glycoproteins 
without any initiator sialyltransferase. It should be noted that 
polysialylation by ST8Sia II as well as IV [9] occurred not only 
for specific glycoproteins such as N-CAM but also for other 
glycoproteins such as fetuin, at least in vitro. Therefore, the 
specific polysialylation of the glycoproteins should depend on 
the structures of the acceptor N-linked oligosaccharides and 
the enzyme expression. 
PSA synthase was first cloned from a mutant cell line of 
Chinese hamster ovary cells [10], and its activity was demon- 
strated using the corresponding soluble enzyme (ST8Sia IV) 
cloned from mouse [9]. It is clear that ST8Sia II (STX) is a 
second type of PSA synthase. Although the genes of both 
ST8Sia II and IV are expressed in the brain, it is not clear why 
two types of PSA synthases are expressed in the same tissue. 
Polysialic acid chains have been shown to exist in N-CAM [24] 
and the c~_subunit of the voltage-gated sodium channel in rat 
brain [5]. Therefore, the two different PSA synthases may be 
responsible for the polysialylation of the two specific glycopro- 
teins, respectively. An alternative possibility isthat the two PSA 
synthases may be involved in the polysialylation of the embry- 
onic and the postponal forms of N-CAM, respectively, because 
the expression of polysialic acids on N-CAM is developmen- 
tally regulated [2~t]. Comparison of the expression and the 
activities of ST8Sia II and IV, and structural analysis of the 
polysialylated N-linked oligosaccharides of several glycopro- 
teins including N-CAM using the two cloned PSA synthases i
required to answer the above questions. Studies along these 
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Fig. 3. ST8Sia II induces polysialic acid expression. (A) The plasmid (2/lg), pcDSA-O1, was transiently transfected into NIH3T3 cells by means of 
lipofectamine. After 72 h incubation, the cells were stained with H.46, as described in section 2. (B) The plasmid DNA (2 gtg) of pRc/CMV or 
pRc/CMV-ST8Sia II was transfected into the mouse cell lines, NIH 3T3, Neuro2a nd B16 BL6 and then cells were stained with the anti-polysialic 
acid polyclonal antibody, H.46. (C) Flow cytometric analysis of Neuro2a nd NIH 3T3 cells transfected with pRc/CMV (open peak) or pRc/CMV- 
ST8Sia II (shaded peak). After 72 h of transfection, the cells were harvested and stained with mAb 735. 
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